UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)

163 filings reported holding URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share as of Q4 2024.
UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) has 139 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 36,306,231 shares of 46,239,275 outstanding shares and own 79% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (3,834,794 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2,928,086 shares), BlackRock, Inc. (2,467,211 shares), MENORA MIVTACHIM HOLDINGS LTD. (2,303,031 shares), TORONTO DOMINION BANK (1,749,142 shares), Vestal Point Capital, LP (1,630,000 shares), ACORN CAPITAL ADVISORS, LLC (1,516,303 shares), UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (1,377,156 shares), Nantahala Capital Management, LLC (1,371,638 shares), and SILVERARC CAPITAL MANAGEMENT, LLC (1,120,473 shares).
This table shows the top 139 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.